Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral versus rectal acetaminophen for patent ductus arteriosus closure in preterm neonates
IRCT20130812014333N118Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of acetaminophen in patent ductus arteriosus (PDA) (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Closure of ductus arteriosus in preterm neonates. Started Mar 2019; status: completed.
02
Drugs
acetaminophen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on IRCT20130812014333N118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130812014333N118.